Chronic vagal nerve stimulation improves baroreflex neural arc function in heart failure rats
Toru Kawada1, Meihua Li2, Can Zheng2
1Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka, Japan; and torukawa@ncvc.go.jp.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|March 29, 2014
Summary
Vagal stimulation (VS) improved baroreflex control of sympathetic nerve activity in rats post-myocardial infarction (MI). However, this 6-week treatment did not significantly enhance overall baroreflex function impacting arterial pressure.
Area of Science:
- Cardiovascular Physiology
- Autonomic Nervous System Research
- Regenerative Medicine
Background:
- Myocardial infarction (MI) often impairs baroreflex function, crucial for cardiovascular stability.
- Vagal stimulation (VS) is explored as a therapeutic strategy to mitigate post-MI complications.
- Understanding VS effects on baroreflex control is vital for developing new treatments.
Purpose of the Study:
- To evaluate the efficacy of 6-week vagal stimulation (VS) in restoring open-loop baroreflex function after myocardial infarction (MI) in rats.
- To compare baroreflex responses between MI rats with and without VS treatment.
- To assess the impact of VS on both sympathetic nerve activity (SNA) and arterial pressure (AP) regulation.
Main Methods:
- Used Sprague-Dawley rats divided into normal control, MI-no treatment, and MI-VS groups.
- Administered 6-week vagal stimulation (VS) to the MI-VS group.
- Performed open-loop baroreflex testing under anesthesia by stimulating carotid sinus regions.
- Measured splanchnic sympathetic nerve activity (SNA) and arterial pressure (AP) responses.
Main Results:
- Vagal stimulation (VS) significantly increased the response range of splanchnic sympathetic nerve activity (SNA) in MI rats compared to controls (63.8% vs. 33.1%).
- The arterial pressure (AP) response to SNA changes did not show significant improvement with VS treatment.
- The overall baroreflex total-loop function, particularly AP regulation, showed limited enhancement despite improved SNA control.
Conclusions:
- Six-week vagal stimulation (VS) effectively improves baroreflex control of sympathetic nerve activity (SNA) following myocardial infarction (MI) in rats.
- The therapeutic benefit of VS on overall baroreflex function is limited due to insufficient improvement in arterial pressure regulation.
- VS shows potential for modulating autonomic function post-MI, but further research is needed to optimize its impact on cardiovascular stability.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
Neural Regulation of Blood Pressure
8.9K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
8.9K


